The global polymerase chain reaction (PCR) market was valued at US$ 10.1 billion in 2024 and is projected to reach US$ 24.0 billion by 2035. The industry is anticipated to grow at a CAGR of 8.2% from 2025 to 2035, driven by increasing demand for molecular diagnostics, rising prevalence of infectious and genetic diseases, and continuous advancements in diagnostic technologies and precision medicine.

Download Sample of the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=830

Increase in PCR’s usage has allowed it to be a key part of the ongoing expansion of molecular diagnostics and biomedical research. The use of PCR for the identification of nucleic acids with a high level of specificity has made it a vital part of the testing for infectious diseases, genetic analysis of diseases, the study of cancer, and for the development of new treatments based on the characteristics of individual patients. The dependability and versatility of this technology have led to a continued and increasing demand for its use in clinical laboratories, the other research institutions, and in the biotechnology sector.

In addition, the growth of the PCR market has also been supported by more advanced technologies now available in the market. Examples of advancements in PCR technology are real-time PCR, digital PCR, automation, and the use of high-throughput methods for the production of PCR products.

Key Findings of the Market Report

• Based on application, demand for infectious disease testing is expected to drive the market for polymerase chain reaction.
• A greater emphasis on reagents and consumables is likely to create opportunities for PCR market lines to thrive due to continuous repeat purchases.
• Advanced molecular diagnostic systems and amplification hardware are in high demand in the clinical diagnostics industry.
• The dominant market share of global polymerase chain reaction technologies was held by North America in 2024.

Global Polymerase Chain Reaction (PCR) Market: Growth Drivers

• Rising Global Burden of Infectious Diseases and Oncology: The growing prevalence of multi-drug resistant pathogens, respiratory viruses, and specific genetic oncology mutations largely drives the market growth of PCR technologies. High-precision amplification remains the gold standard pathway for early diagnostic validation worldwide.
• Rapid Transition Toward Decentralized Point-of-Care Testing (POCT): As healthcare networks focus on immediate patient triage and reducing laboratory turnaround times, compact PCR systems designed for clinics and emergency departments become more important. These self-contained platforms skip the logistically intensive step of batching tests at central labs.
• Technological Progression of Digital PCR (dPCR) Architectures: Continuous R&D into absolute quantification without standard curves is driving the market penetration of dPCR. The capability to detect extremely rare mutant alleles down to minor percentages makes these systems highly sought-after for liquid biopsies and minimal residual disease tracking.
• Expansion of Biomarker Profiling and Companion Diagnostics: Pharmaceutical developers are increasingly tying advanced therapeutic regimens to specific companion diagnostic assays. As a result, clinical groups are heavily incorporating target-specific PCR validation assays into oncology care paths, expanding long-term kit consumption.
• Increasing Life-Science R&D Budgets and Genomic Projects: Growing national investments into public health genomics and academic biotechnology research spur a continuous demand for advanced reagents. High-volume master mixes, custom primers, and automated thermal cyclers scale in step with rising lab infrastructure funding.

Global Polymerase Chain Reaction (PCR) Market: Regional Landscape

• North America is expected to lead the market for polymerase chain reaction systems. Adoption is closely tied to advanced laboratory infrastructure networks, early clinical integration of precision oncology assays, and robust medical reimbursement frameworks across the United States and Canada. The North American region maintains an extensive concentration of established biotechnology hubs, ensuring steady procurement of high-margin consumables.
• Government healthcare policies and pandemic-preparedness directives can also affect the structural demand for molecular testing equipment. Asia-Pacific and European regulatory bodies have steadily increased financial subsidies for localized infectious disease surveillance networks, which may drive the global demand for advanced multiplex assays. The demand for decentralized testing units is growing rapidly across regional diagnostic lab chains, contributing significantly to overall technology demand.

Global Polymerase Chain Reaction (PCR) Market: Key Players

Major polymerase chain reaction manufacturers are using several organic and inorganic growth strategies to expand their market presence. Their production capability is being expanded to meet the increase in demand.

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Danaher Corporation (Cepheid)
• Agilent Technologies, Inc.
• bioMérieux S.A.
• Abbott Laboratories
• Becton, Dickinson and Company
• Takara Bio Inc.

Key Developments

• In February 2025, Bio-Rad Laboratories announced a binding offer to acquire Stilla Technologies, aiming to strengthen its digital PCR portfolio and accelerate the development of next-generation, high-throughput microfluidic molecular diagnostic solutions.
• In mid-2025, diagnostic testing providers expanded automated syndromic panels globally to counter shifting patterns of seasonal respiratory pathogens, consolidating sample-to-answer steps onto singular, fully closed thermal cycling instruments.

Global Polymerase Chain Reaction (PCR) Market: Segmentation

• By Product Type
• Reagents & Consumables (Master Mixes, Primers, Probes, Buffers)
• Instruments (Thermal Cyclers, Real-time Systems, Digital Readers)
• Software & Services
• By Technology
• Real-Time PCR (qPCR)
• Digital PCR (dPCR)
• End-Point / Conventional PCR
• By Application
• Clinical Diagnostics (Infectious Diseases, Oncology, Genetics, Blood Screening)
• Academic & Life Science Research
• Forensic Laboratories
• Non-Medical Applications (Food Safety & Environmental Testing)
• By End User
• Hospitals & Diagnostic Reference Laboratories
• Academic & Research Institutes
• Pharma & Biotech Companies / CROs
• Forensic and Testing Service Providers
• By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Buy this Premium Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=830&ltype=S

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com